FIELD: medicine.
SUBSTANCE: method involves determining epidemic HIV-infection risk as a result of population screening examination by applying immunoenzyme analysis in various groups. Positive result confirmability coefficient is determined in every group in reference study as immune blot and establish that the higher is the confirmability coefficient value, the higher is epidemic HIV-infection risk in particular population group. The confirmability coefficient value is determined from a formula.
EFFECT: high accuracy in evaluating risk.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF EVOLUTIONARY MODELING OF EPIDEMIC DYNAMICS OF HIV INFECTION | 2017 |
|
RU2677002C1 |
| DS-IFA-VICH-AT-SROK ENZYME IMMUNOASSAY SYSTEM FOR DETERMINING PROBABLE TIME OF INTRODUCTION OF TYPE 1 HUMAN IMMUNODEFICIENCY VIRUS (HIV-1) INFECTION, INCLUDING GROUP O HIV-1 IN HUMAN SERUM (PLASMA) | 2013 |
|
RU2515051C1 |
| METHOD FOR OBSTERIC RISK PREDICTION FOR PREGNANT WOMEN AFFECTED BY HIV INFECTION | 2016 |
|
RU2621842C2 |
| METHOD OF PREDICTING PROGRESSION OF HIV INFECTION IN PATIENTS RECEIVING ANTIRETROVIRAL THERAPY | 2019 |
|
RU2697392C1 |
| METHOD FOR ANALYSING AND PREDICTING DEVELOPMENT OF EPIDEMICAL SITUATION CAUSED BY SOCIALLY MINDED AIRBORNE INFECTIONS | 2014 |
|
RU2572227C2 |
| METHOD FOR ENZYME IMMUNOASSAY DETERMINATION OF THE LEVEL OF ANTIGEN-RECOGNIZING B-LYMPHOCYTE RECEPTORS REPRESENTED BY MEMBRANE-SPECIFIC RBD PROTEIN SARS-COV-2, IgG ANTIBODIES | 2021 |
|
RU2760438C1 |
| METHOD FOR DIAGNOSING THE CASES OF PSEUDOTUBERCULOSIS | 1998 |
|
RU2153172C1 |
| METHOD FOR PREDICTING THE EFFECTIVENESS OF ANTIRETROVIRAL THERAPY FOR CO-INFECTION WITH TUBERCULOSIS AND HIV INFECTION | 2017 |
|
RU2666223C1 |
| METHOD FOR PREDICTION OF LETHAL OUTCOME IN CLINICAL COURSE OF COINFECTION OF HIV AND TUBERCULOSIS, ACCOMPANIED BY MULTIPLE DRUG-RESISTANT MYCOBACTERIUM TUBERCULOSIS | 2019 |
|
RU2710266C1 |
| METHOD OF DIAGNOSING HYPERVIRUS EYE DISEASES | 2006 |
|
RU2400756C2 |
